Pub Date : 2024-09-20DOI: 10.1186/s12880-024-01425-y
Mousa Alhajlah
Background: Breast cancer is one of the leading diseases worldwide. According to estimates by the National Breast Cancer Foundation, over 42,000 women are expected to die from this disease in 2024.
Objective: The prognosis of breast cancer depends on the early detection of breast micronodules and the ability to distinguish benign from malignant lesions. Ultrasonography is a crucial radiological imaging technique for diagnosing the illness because it allows for biopsy and lesion characterization. The user's level of experience and knowledge is vital since ultrasonographic diagnosis relies on the practitioner's expertise. Furthermore, computer-aided technologies significantly contribute by potentially reducing the workload of radiologists and enhancing their expertise, especially when combined with a large patient volume in a hospital setting.
Method: This work describes the development of a hybrid CNN system for diagnosing benign and malignant breast cancer lesions. The models InceptionV3 and MobileNetV2 serve as the foundation for the hybrid framework. Features from these models are extracted and concatenated individually, resulting in a larger feature set. Finally, various classifiers are applied for the classification task.
Results: The model achieved the best results using the softmax classifier, with an accuracy of over 95%.
Conclusion: Computer-aided diagnosis greatly assists radiologists and reduces their workload. Therefore, this research can serve as a foundation for other researchers to build clinical solutions.
{"title":"A hybrid features fusion-based framework for classification of breast micronodules using ultrasonography.","authors":"Mousa Alhajlah","doi":"10.1186/s12880-024-01425-y","DOIUrl":"https://doi.org/10.1186/s12880-024-01425-y","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer is one of the leading diseases worldwide. According to estimates by the National Breast Cancer Foundation, over 42,000 women are expected to die from this disease in 2024.</p><p><strong>Objective: </strong>The prognosis of breast cancer depends on the early detection of breast micronodules and the ability to distinguish benign from malignant lesions. Ultrasonography is a crucial radiological imaging technique for diagnosing the illness because it allows for biopsy and lesion characterization. The user's level of experience and knowledge is vital since ultrasonographic diagnosis relies on the practitioner's expertise. Furthermore, computer-aided technologies significantly contribute by potentially reducing the workload of radiologists and enhancing their expertise, especially when combined with a large patient volume in a hospital setting.</p><p><strong>Method: </strong>This work describes the development of a hybrid CNN system for diagnosing benign and malignant breast cancer lesions. The models InceptionV3 and MobileNetV2 serve as the foundation for the hybrid framework. Features from these models are extracted and concatenated individually, resulting in a larger feature set. Finally, various classifiers are applied for the classification task.</p><p><strong>Results: </strong>The model achieved the best results using the softmax classifier, with an accuracy of over 95%.</p><p><strong>Conclusion: </strong>Computer-aided diagnosis greatly assists radiologists and reduces their workload. Therefore, this research can serve as a foundation for other researchers to build clinical solutions.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11415982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142280163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The analysis of the psoas muscle in morphological and functional imaging has proved to be an accurate approach to assess sarcopenia, i.e. a systemic loss of skeletal muscle mass and function that may be correlated to multifactorial etiological aspects. The inclusion of sarcopenia assessment into a radiological workflow would need the implementation of computational pipelines for image processing that guarantee segmentation reliability and a significant degree of automation. The present study utilizes three-dimensional numerical schemes for psoas segmentation in low-dose X-ray computed tomography images. Specifically, here we focused on the level set methodology and compared the performances of two standard approaches, a classical evolution model and a three-dimension geodesic model, with the performances of an original first-order modification of this latter one. The results of this analysis show that these gradient-based schemes guarantee reliability with respect to manual segmentation and that the first-order scheme requires a computational burden that is significantly smaller than the one needed by the second-order approach.
腰肌形态学和功能成像分析已被证明是评估 "肌肉疏松症 "的准确方法。"肌肉疏松症 "是指骨骼肌质量和功能的系统性丧失,可能与多种病因有关。要将肌肉疏松症评估纳入放射学工作流程,就必须实施图像处理计算管道,以保证分割的可靠性和高度自动化。本研究利用三维数值方案对低剂量 X 射线计算机断层扫描图像中的腰肌进行分割。具体来说,我们将重点放在水平集方法上,并比较了两种标准方法(经典演化模型和三维大地模型)的性能,以及后一种方法的原始一阶修改的性能。分析结果表明,这些基于梯度的方案保证了人工分割的可靠性,而且一阶方案所需的计算负担明显小于二阶方法。
{"title":"Three-dimensional numerical schemes for the segmentation of the psoas muscle in X-ray computed tomography images.","authors":"Giulio Paolucci, Isabella Cama, Cristina Campi, Michele Piana","doi":"10.1186/s12880-024-01423-0","DOIUrl":"https://doi.org/10.1186/s12880-024-01423-0","url":null,"abstract":"<p><p>The analysis of the psoas muscle in morphological and functional imaging has proved to be an accurate approach to assess sarcopenia, i.e. a systemic loss of skeletal muscle mass and function that may be correlated to multifactorial etiological aspects. The inclusion of sarcopenia assessment into a radiological workflow would need the implementation of computational pipelines for image processing that guarantee segmentation reliability and a significant degree of automation. The present study utilizes three-dimensional numerical schemes for psoas segmentation in low-dose X-ray computed tomography images. Specifically, here we focused on the level set methodology and compared the performances of two standard approaches, a classical evolution model and a three-dimension geodesic model, with the performances of an original first-order modification of this latter one. The results of this analysis show that these gradient-based schemes guarantee reliability with respect to manual segmentation and that the first-order scheme requires a computational burden that is significantly smaller than the one needed by the second-order approach.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11414197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142280165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-18DOI: 10.1186/s12880-024-01408-z
Ramy M. Ahmed, Wageeh A. Ali, Ahmed M. AbdelHakam, Sayed H. Ahmed
Accurate detection of Hepatocellular carcinoma (HCC) feeding vessels during transcatheter arterial chemoembolization (TACE) is important for an effective treatment, while limiting non-target embolization. This study aimed to investigate the feasibility and accuracy of pre-TACE three dimensional (3D) CT angiography for tumor-feeding vessels detection compared to DSA. Sixty-nine consecutive patients referred for TACE from May 2022 to May 2023 were included. (3D) CT images were reconstructed from the pre-TACE diagnostic multiphasic contrast enhanced CT images and compared with non-selective digital subtraction angiography (DSA) images obtained during TACE for detection of HCC feeding vessels. A “Ground truth” made by consensus between observers after reviewing all available pre-TACE CT images, and DSA and CBCT images during TACE to detect the true feeding vessels was the gold standard. Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), accuracy and ROC curve with AUC were calculated for each modality and compared. A total of 136 active HCCs were detected in the 69 consecutive patients included in the study. 185 feeding arteries were detected by 3D CT and DSA and included in the analysis. 3D CT detection of feeding arteries revealed mean sensitivity, specificity, PPV, NPV and accuracy of 91%, 71%, 98%, 36%, and 90%, respectively, with mean AUC = 0.81. DSA detection of feeding arteries revealed mean sensitivity, specificity, PPV, NPV, and accuracy of 80%, 58%, 96.5%, 16.5% and 78%, respectively, with mean AUC = 0.69. Pre-TACE 3D CT angiography has shown promise in improving the detection of HCC feeding vessels compared to DSA. However, further studies are required to confirm these findings across different clinical settings and patient populations. This study was prospectively registered at Clinicaltrials.gov with ID NCT05304572; Date of registration: 2-4-2022.
{"title":"Detection of hepatocellular carcinoma feeding vessels: MDCT angiography with 3D reconstruction versus digital subtraction angiography","authors":"Ramy M. Ahmed, Wageeh A. Ali, Ahmed M. AbdelHakam, Sayed H. Ahmed","doi":"10.1186/s12880-024-01408-z","DOIUrl":"https://doi.org/10.1186/s12880-024-01408-z","url":null,"abstract":"Accurate detection of Hepatocellular carcinoma (HCC) feeding vessels during transcatheter arterial chemoembolization (TACE) is important for an effective treatment, while limiting non-target embolization. This study aimed to investigate the feasibility and accuracy of pre-TACE three dimensional (3D) CT angiography for tumor-feeding vessels detection compared to DSA. Sixty-nine consecutive patients referred for TACE from May 2022 to May 2023 were included. (3D) CT images were reconstructed from the pre-TACE diagnostic multiphasic contrast enhanced CT images and compared with non-selective digital subtraction angiography (DSA) images obtained during TACE for detection of HCC feeding vessels. A “Ground truth” made by consensus between observers after reviewing all available pre-TACE CT images, and DSA and CBCT images during TACE to detect the true feeding vessels was the gold standard. Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), accuracy and ROC curve with AUC were calculated for each modality and compared. A total of 136 active HCCs were detected in the 69 consecutive patients included in the study. 185 feeding arteries were detected by 3D CT and DSA and included in the analysis. 3D CT detection of feeding arteries revealed mean sensitivity, specificity, PPV, NPV and accuracy of 91%, 71%, 98%, 36%, and 90%, respectively, with mean AUC = 0.81. DSA detection of feeding arteries revealed mean sensitivity, specificity, PPV, NPV, and accuracy of 80%, 58%, 96.5%, 16.5% and 78%, respectively, with mean AUC = 0.69. Pre-TACE 3D CT angiography has shown promise in improving the detection of HCC feeding vessels compared to DSA. However, further studies are required to confirm these findings across different clinical settings and patient populations. This study was prospectively registered at Clinicaltrials.gov with ID NCT05304572; Date of registration: 2-4-2022.","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142256549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breast cancer prediction and diagnosis are critical for timely and effective treatment, significantly impacting patient outcomes. Machine learning algorithms have become powerful tools for improving the prediction and diagnosis of breast cancer. The Breast Cancer Prediction and Diagnosis Model (BCPM), which utilises machine learning techniques to improve the precision and efficiency of breast cancer diagnosis and prediction, is presented in this paper. BCPM collects comprehensive and high-quality data from diverse sources, including electronic medical records, clinical trials, and public datasets. Through rigorous pre-processing, the data is cleaned, inconsistencies are addressed, and missing values are handled. Feature scaling techniques are applied to normalize the data, ensuring fair comparison and equal importance among different features. Furthermore, feature-selection algorithms are utilized to identify the most relevant features that contribute to breast cancer projection and diagnosis, optimizing the model’s efficiency. The BCPM employs numerous machine learning methods, such as logistic regression, random forests, decision trees, support vector machines, and neural networks, to generate accurate models. Area under the curve (AUC), sensitivity, specificity, and accuracy are only some of the metrics used to assess a model’s performance once it has been trained on a subset of data. The BCPM holds promise in improving breast cancer prediction and diagnosis, aiding in personalized treatment planning, and ultimately taming patient results. By leveraging machine learning algorithms, the BCPM contributes to ongoing efforts in combating breast cancer and saving lives.
{"title":"The BCPM method: decoding breast cancer with machine learning","authors":"Badar Almarri, Gaurav Gupta, Ravinder Kumar, Vandana Vandana, Fatima Asiri, Surbhi Bhatia Khan","doi":"10.1186/s12880-024-01402-5","DOIUrl":"https://doi.org/10.1186/s12880-024-01402-5","url":null,"abstract":"Breast cancer prediction and diagnosis are critical for timely and effective treatment, significantly impacting patient outcomes. Machine learning algorithms have become powerful tools for improving the prediction and diagnosis of breast cancer. The Breast Cancer Prediction and Diagnosis Model (BCPM), which utilises machine learning techniques to improve the precision and efficiency of breast cancer diagnosis and prediction, is presented in this paper. BCPM collects comprehensive and high-quality data from diverse sources, including electronic medical records, clinical trials, and public datasets. Through rigorous pre-processing, the data is cleaned, inconsistencies are addressed, and missing values are handled. Feature scaling techniques are applied to normalize the data, ensuring fair comparison and equal importance among different features. Furthermore, feature-selection algorithms are utilized to identify the most relevant features that contribute to breast cancer projection and diagnosis, optimizing the model’s efficiency. The BCPM employs numerous machine learning methods, such as logistic regression, random forests, decision trees, support vector machines, and neural networks, to generate accurate models. Area under the curve (AUC), sensitivity, specificity, and accuracy are only some of the metrics used to assess a model’s performance once it has been trained on a subset of data. The BCPM holds promise in improving breast cancer prediction and diagnosis, aiding in personalized treatment planning, and ultimately taming patient results. By leveraging machine learning algorithms, the BCPM contributes to ongoing efforts in combating breast cancer and saving lives.","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142256552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-17DOI: 10.1186/s12880-024-01412-3
Zhenyan Ye, Ying Kou, Jiaqi Shen, Jun Dang, Xiaofei Tan, Xiao Jiang, Xiaoxiong Wang, Hao Lu, Shirong Chen, Zhuzhong Cheng
<p>Correction to: Ye et al. BMC Medical Imaging (2024) 24:192 https://doi.org/10.1186/s12880-024-01376-4.</p><p>Following the publication of the Original Article, the authors discovered that Tables 2 and 3 contained errors. The tables were mistakenly included in their original, unmodified form, leading to discrepancies between the tables and the rest of the paper.</p><p>In statistical work, the authors used a “2” to label patients with PSA levels greater than 10. PSA less than 10 was marked with “1”, and the number of patients with PSA levels higher than 10 and lower than 10 were counted respectively.</p><p>However, in Table 3, “1” and “2” were wrongly counted as the PSA levels of patients. Therefore, certain parts of the article need to be updated accordingly.</p><p><b>Incorrect</b>.</p><figure><figcaption><b data-test="table-caption">Table 2 Clinical, radiological and molecular patient characteristics</b></figcaption><span>Full size table</span><svg aria-hidden="true" focusable="false" height="16" role="img" width="16"><use xlink:href="#icon-eds-i-chevron-right-small" xmlns:xlink="http://www.w3.org/1999/xlink"></use></svg></figure><figure><figcaption><b data-test="table-caption">Table 3 Patients with discordant magnetic resonance imaging and prostatespecific membrane antigen positron emission tomography/computed tomography findings</b></figcaption><span>Full size table</span><svg aria-hidden="true" focusable="false" height="16" role="img" width="16"><use xlink:href="#icon-eds-i-chevron-right-small" xmlns:xlink="http://www.w3.org/1999/xlink"></use></svg></figure><p><b>Correct</b>.</p><figure><figcaption><b data-test="table-caption">Table 2 Clinical, radiological and molecular patient characteristics</b></figcaption><span>Full size table</span><svg aria-hidden="true" focusable="false" height="16" role="img" width="16"><use xlink:href="#icon-eds-i-chevron-right-small" xmlns:xlink="http://www.w3.org/1999/xlink"></use></svg></figure><figure><figcaption><b data-test="table-caption">Table 3 Patients with discordant magnetic resonance imaging and prostatespecific membrane antigen positron emission tomography/computed tomography findings</b></figcaption><span>Full size table</span><svg aria-hidden="true" focusable="false" height="16" role="img" width="16"><use xlink:href="#icon-eds-i-chevron-right-small" xmlns:xlink="http://www.w3.org/1999/xlink"></use></svg></figure><p><b>In the Results section:</b></p><ul>